Fludarabin Actavis 25 mg/ ml Norvège - norvégien - Statens legemiddelverk

fludarabin actavis 25 mg/ ml

actavis group ptc ehf - fludarabinfosfat - konsentrat til injeksjons-/infusjonsvæske, oppløsning - 25 mg/ ml

Lisinopril/Hydroklortiazid Actavis 20 mg / 12.5 mg Norvège - norvégien - Statens legemiddelverk

lisinopril/hydroklortiazid actavis 20 mg / 12.5 mg

actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 20 mg / 12.5 mg

Lisinopril/Hydroklortiazid Actavis 10 mg / 12.5 mg Norvège - norvégien - Statens legemiddelverk

lisinopril/hydroklortiazid actavis 10 mg / 12.5 mg

actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 10 mg / 12.5 mg

Stesolid 5 mg/ ml Norvège - norvégien - Statens legemiddelverk

stesolid 5 mg/ ml

actavis group ptc ehf (1) - diazepam - injeksjonsvæske, emulsjon - 5 mg/ ml

Stesolid 5 mg/2.5 ml Norvège - norvégien - Statens legemiddelverk

stesolid 5 mg/2.5 ml

actavis group ptc ehf (1) - diazepam - rektalvæske, oppløsning - 5 mg/2.5 ml

Stesolid 10 mg/2.5 ml Norvège - norvégien - Statens legemiddelverk

stesolid 10 mg/2.5 ml

actavis group ptc ehf (1) - diazepam - rektalvæske, oppløsning - 10 mg/2.5 ml

Imatinib Actavis Union européenne - norvégien - EMA (European Medicines Agency)

imatinib actavis

actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. effekten av imatinib på utfallet av bein marg transplantasjon har ikke fastsatt. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. erfaring med imatinib hos pasienter med mds/mpd forbundet med pdgfr gene re-ordninger er svært begrenset. det er ingen kontrollerte studier som viser en klinisk nytte eller økt overlevelse for disse sykdommer.

Zoledronic acid Actavis Union européenne - norvégien - EMA (European Medicines Agency)

zoledronic acid actavis

actavis group ptc ehf   - zoledronsyre monohydrat - frakturer, bein - legemidler til behandling av bein sykdommer - forebygging av skjelettrelaterte hendelser (patologiske frakturer, spinalkompresjon, stråling eller operasjon til bein eller tumorinducert hyperkalsemi) hos voksne pasienter med avanserte maligniteter som involverer bein. behandling av voksne pasienter med tumor-indusert hyperkalsemi.

Apocillin 330 mg Norvège - norvégien - Statens legemiddelverk

apocillin 330 mg

actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 330 mg

Apocillin 250 mg/ ml Norvège - norvégien - Statens legemiddelverk

apocillin 250 mg/ ml

actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - granulat til dråper, oppløsning - 250 mg/ ml